Guidelines for the Management of Substance ... - HOme - Home

Guideline

Guidelines for the Management of Substance Use During Pregnancy Birth

and the Postnatal Period

Summary These guidelines support and provide best practice advice to health professionals in

the management of drug use during pregnancy, birth and early development years of

the newborn.

Document type Guideline

Document number GL2014_022

Publication date 17 December 2014

Author branch Centre for Alcohol and Other Drugs

Branch contact (02) 9424 5938

Review date 17 December 2019

Policy manual Patient Matters

File number 11/5552

Previous reference N/A

Status Active

Functional group Clinical/Patient Services - Governance and Service Delivery, Baby and Child

Applies to Local Health Districts, Board Governed Statutory Health Corporations, Chief

Executive Governed Statutory Health Corporations, Specialty Network Governed

Statutory Health Corporations, Affiliated Health Organisations, Community Health

Centres, NSW Ambulance Service, Private Hospitals and day Procedure Centres,

Public Health Units, Public Hospitals

Distributed to Public Health System, Divisions of General Practice, Government Medical Officers,

Ministry of Health, Tertiary Education Institutes

Audience Medical Practicioners;Nursing;Clinical;Allied Health;Midwifery

Secretary, NSW Health

GUIDELINE SUMMARY

NSW CLINICAL GUIDELINES FOR THE MANAGEMENT OF

SUBSTANCE USE DURING PREGNANCY, BIRTH AND THE

POSTNATAL PERIOD

PURPOSE

These clinical guidelines are intended to support a range of health care workers who

care for pregnant and breastfeeding women with substance use issues, and their infants

and families.

KEY PRINCIPLES

The guidelines emphasise the importance of establishing a sound therapeutic

relationship with the woman based on respect and non-judgmental attitudes, of

engaging the woman into adequate antenatal care through this relationship, and of

maintaining continuity of care and of carers throughout the pregnancy and postnatal

period.

The guidelines recommend that pregnant women with significant problematic substance

use will benefit from an appropriate referral for specialist drug and alcohol assessment

(in addition to midwifery and obstetric care), appointment of a consistent and continuous

case manager and care team who use effective communication systems, and specific

treatments for their substance use, which may include counselling, pharmacotherapies

and relapse prevention strategies.

USE OF THE GUIDELINE

These guidelines are intended for use by all health care practitioners in NSW working

with pregnant women who are using substances during pregnancy, and the postnatal

period. Substances refers to both licit purposes, such as those prescribed for pain relief,

substance use treatment or other issues, and illicit purposes, which can include

prescribed substances used for purposes other than that prescribed, and illicit

substances.

Substances discussed in these guidelines include the licit substances of alcohol and

tobacco; illicit substances of opioids, amphetamine-type stimulants (ATS), cocaine,

cannabis and inhalants; and prescription medication which can be used licitly or illicitly.

Other topics covered include breastfeeding, vertical transmission of blood-borne

viruses, obstetric implications, pain management during labour, psychosocial issues,

the management of Neonatal Abstinence Syndrome and early childhood development.

This NSW revision of the guidelines has chapters specifically addressing the needs of

women who are incarcerated or at risk of incarceration, women who live in rural and/or

remote locations, and Aboriginal women. New legislation pertaining to child protection in

NSW is also covered in detail.

GL2014_022

Issue date: December- 2014

Page 1 of 2

GUIDELINE SUMMARY

REVISION HISTORY

Version

GL2014_022

December

2014

Approved by

Deputy Secretary,

Systems

Purchasing and

Performance

Amendment notes

New policy

ATTACHMENTS

1. Guidelines for the Management of Substance Use During Pregnancy Birth and the

Postnatal Period.

GL2014_022

Issue date: December- 2014

Page 2 of 2

CLINICAL GUIDELINES

FOR THE MANAGEMENT OF

SUBSTANCE USE DURING

PREGNANCY, BIRTH AND THE

POSTNATAL PERIOD

NSW MINISTRY OF HEALTH

73 Miller Street

NORTH SYDNEY NSW 2060

Tel. (02) 9391 9000

Fax. (02) 9391 9101

TTY. (02) 9391 9900

health..au

? NSW Ministry of Health 2014

SHPN (MHDAO) 140396

ISBN 978-1-74187-069-5

This work is copyright. Copies may be made for teaching, clinical work and other

non-profit making enterprises.

DISCLAIMER: While every care has been taken to ensure the accuracy and currency

of the information contained in this document at the time of writing, it is possible that

additional or updated information relating to some of the content in this report may

have emerged prior to publication.

Further copies of this document can be downloaded from the

NSW Health website health..au

October 2014

 ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download